NCT04355169View on ClinicalTrials.gov

A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 6, 2020

Primary Completion Date

January 4, 2021

Study Completion Date

January 4, 2021

Conditions
Postoperative Gastrointestinal Dysfunction
Interventions
DRUG

Naldemedine

Oral tablet

DRUG

Placebo

Oral tablet

Trial Locations (8)

40202

Norton Hospital, Louisville

University of Louisville Hospital, Louisville

40208

University of Louisville Division of Surgery, Louisville

75701

CHRISTUS Mother Frances Hospital - Tyler, Tyler

75702

CHRISTUS Trinity Clinic Research, Tyler

CHRISTUS Trinity Clinic Surgical Oncology, Tyler

77030

Houston Methodist Hospital, Houston

85719

Banner University Medical Center - Tucson, Tucson

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY